Found: 53
Select item for more details and to access through your institution.
Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Correction to: Monoclonal anti‑CGRP antibodies in post‑menopausal women: a real‑life study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study.
- Published in:
- Acta Neurologica Belgica, 2023, v. 123, n. 3, p. 1039, doi. 10.1007/s13760-023-02190-5
- By:
- Publication type:
- Article
Migraine Awareness in Italy and the Myth of "Cervical Arthrosis".
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 1, p. 81, doi. 10.1111/head.13679
- By:
- Publication type:
- Article
Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)—a pilot study.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 11, p. 1427, doi. 10.1007/s00228-018-2516-3
- By:
- Publication type:
- Article
Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2021.647995
- By:
- Publication type:
- Article
Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real‐world clinical evidence in a severely impaired patient population.
- Published in:
- Brain & Behavior, 2023, v. 13, n. 6, p. 1, doi. 10.1002/brb3.2799
- By:
- Publication type:
- Article
Predictors of response to erenumab after 12 months of treatment.
- Published in:
- Brain & Behavior, 2021, v. 11, n. 8, p. 1, doi. 10.1002/brb3.2260
- By:
- Publication type:
- Article
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study.
- Published in:
- CNS Drugs, 2023, v. 37, n. 12, p. 1069, doi. 10.1007/s40263-023-01050-3
- By:
- Publication type:
- Article
Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.774341
- By:
- Publication type:
- Article
OnabotulinumtoxinA: Still the Present for Chronic Migraine.
- Published in:
- Toxins, 2023, v. 15, n. 1, p. 59, doi. 10.3390/toxins15010059
- By:
- Publication type:
- Article
Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal.
- Published in:
- Journal of Headache & Pain, 2017, v. 18, n. 1, p. 1, doi. 10.1186/s10194-017-0777-3
- By:
- Publication type:
- Article
A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants.
- Published in:
- Journal of Headache & Pain, 2016, v. 17, n. 1, p. 1, doi. 10.1186/s10194-016-0705-y
- By:
- Publication type:
- Article
Correction: The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review.
- Published in:
- Pain & Therapy, 2024, v. 13, n. 3, p. 319, doi. 10.1007/s40122-024-00581-x
- By:
- Publication type:
- Article
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients.
- Published in:
- Pain & Therapy, 2021, v. 10, n. 2, p. 1605, doi. 10.1007/s40122-021-00328-y
- By:
- Publication type:
- Article
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study.
- Published in:
- Pain & Therapy, 2021, v. 10, n. 1, p. 637, doi. 10.1007/s40122-021-00253-0
- By:
- Publication type:
- Article
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY).
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 415, doi. 10.1007/s40120-024-00582-0
- By:
- Publication type:
- Article
Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Secondary spontaneous pneumothorax and bullous lung disease in cannabis and tobacco smokers: A case-control study.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230419
- By:
- Publication type:
- Article
Nabilone administration in refractory chronic diarrhea: a case series.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical Evidence of Cannabinoids in Migraine: A Narrative Review.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1479, doi. 10.3390/jcm11061479
- By:
- Publication type:
- Article
Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life study.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 4, p. 1661, doi. 10.1007/s10072-023-07167-z
- By:
- Publication type:
- Article
Gender-related stress factors and emotional perception in migraine: a structured online questionnaire in migraine patients and controls.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 4, p. 1645, doi. 10.1007/s10072-023-07152-6
- By:
- Publication type:
- Article
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ).
- Published in:
- Neurological Sciences, 2023, v. 44, n. 8, p. 2845, doi. 10.1007/s10072-023-06758-0
- By:
- Publication type:
- Article
The association between onabotulinumtoxinA and anti-CGRP monoclonal antibodies: a reliable option for the optimal treatment of chronic migraine.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 9, p. 5687, doi. 10.1007/s10072-022-06195-5
- By:
- Publication type:
- Article
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 2, p. 1273, doi. 10.1007/s10072-021-05426-5
- By:
- Publication type:
- Article
Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 10, p. 4193, doi. 10.1007/s10072-021-05105-5
- By:
- Publication type:
- Article
Nummular headache: a gender-oriented perspective on a case series from the RegistRare Network.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A case-control study of visually evoked postural responses in childhood with primary headaches.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy.
- Published in:
- Frontiers in Neurology, 2017, p. 1, doi. 10.3389/fneur.2017.00586
- By:
- Publication type:
- Article
Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment.
- Published in:
- Journal of Headache & Pain, 2016, v. 17, n. 1, p. 1, doi. 10.1186/s10194-016-0634-9
- By:
- Publication type:
- Article
Proteomic research of proteins involved in pain expression in an animal model of chronic pain.
- Published in:
- Journal of Headache & Pain, 2015, v. 16, p. 1, doi. 10.1186/1129-2377-16-S1-A8
- By:
- Publication type:
- Article
P045. OnabotulinumtoxinA: long term treatment for chronic migraine with medication overuse.
- Published in:
- 2015
- By:
- Publication type:
- Abstract
Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache.
- Published in:
- Journal of Headache & Pain, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s10194-015-0559-8
- By:
- Publication type:
- Article
Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey.
- Published in:
- Journal of Headache & Pain, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1129-2377-14-48
- By:
- Publication type:
- Article
Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache
- Published in:
- Journal of Headache & Pain, 2013, v. 14, n. 1, p. 6, doi. 10.1186/1129-2377-14-6
- By:
- Publication type:
- Article
Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study.
- Published in:
- Journal of Headache & Pain, 2012, v. 13, n. 8, p. 669, doi. 10.1007/s10194-012-0484-z
- By:
- Publication type:
- Article
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial.
- Published in:
- Journal of Headache & Pain, 2012, v. 13, n. 8, p. 677, doi. 10.1007/s10194-012-0490-1
- By:
- Publication type:
- Article
Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages.
- Published in:
- Journal of Headache & Pain, 2012, v. 13, n. 1, p. 45, doi. 10.1007/s10194-011-0390-9
- By:
- Publication type:
- Article
Basal cutaneous pain threshold in headache patients.
- Published in:
- Journal of Headache & Pain, 2011, v. 12, n. 3, p. 303, doi. 10.1007/s10194-011-0313-9
- By:
- Publication type:
- Article
Spotlight on Anti‐CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 534, doi. 10.1002/cpdd.345
- By:
- Publication type:
- Article
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 11, p. 5436, doi. 10.1007/s00415-023-11872-2
- By:
- Publication type:
- Article
Efficacy of transdermal rotigotine in chronic cluster headache: A case series.
- Published in:
- Cephalalgia Reports, 2018, v. 1, p. 1, doi. 10.1177/2515816318809697
- By:
- Publication type:
- Article
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache.
- Published in:
- Cephalalgia, 2022, v. 42, n. 7, p. 645, doi. 10.1177/03331024211067791
- By:
- Publication type:
- Article
Identification of candidate proteomic markers in the serum of medication overuse headache patients: An exploratory study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rare primary headaches in Italian tertiary Headache Centres: Three year nationwide retrospective data from the RegistRare Network.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review.
- Published in:
- Drug, Healthcare & Patient Safety, 2021, v. 13, p. 233, doi. 10.2147/DHPS.S304373
- By:
- Publication type:
- Article
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01408-w
- By:
- Publication type:
- Article